BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24103911)

  • 1. Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis.
    Harlalka GV; Lehman A; Chioza B; Baple EL; Maroofian R; Cross H; Sreekantan-Nair A; Priestman DA; Al-Turki S; McEntagart ME; Proukakis C; Royle L; Kozak RP; Bastaki L; Patton M; Wagner K; Coblentz R; Price J; Mezei M; Schlade-Bartusiak K; Platt FM; Hurles ME; Crosby AH
    Brain; 2013 Dec; 136(Pt 12):3618-24. PubMed ID: 24103911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation.
    Trinchera M; Parini R; Indellicato R; Domenighini R; dall'Olio F
    Mol Genet Metab; 2018 Aug; 124(4):230-237. PubMed ID: 29983310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Enzyme Activity in Mutated B4GALNT1 Gene Products in Patients with Hereditary Spastic Paraplegia Results in Relatively Mild Neurological Disorders: Similarity with Phenotypes of B4galnt1 Knockout Mice.
    Bhuiyan RH; Ohmi Y; Ohkawa Y; Zhang P; Takano M; Hashimoto N; Okajima T; Furukawa K; Furukawa K
    Neuroscience; 2019 Jan; 397():94-106. PubMed ID: 30521973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional validation of novel variants in B4GALNT1 associated with early-onset complex hereditary spastic paraplegia with impaired ganglioside synthesis.
    Alecu JE; Ohmi Y; Bhuiyan RH; Inamori KI; Nitta T; Saffari A; Jumo H; Ziegler M; de Gusmao CM; Sharma N; Ohno S; Manabe N; Yamaguchi Y; Kambe M; Furukawa K; Sahin M; Inokuchi JI; Furakawa K; Ebrahimi-Fakhari D
    Am J Med Genet A; 2022 Sep; 188(9):2590-2598. PubMed ID: 35775650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis.
    Sandhoff K; Harzer K
    J Neurosci; 2013 Jun; 33(25):10195-208. PubMed ID: 23785136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital Disorders of Ganglioside Biosynthesis.
    Li TA; Schnaar RL
    Prog Mol Biol Transl Sci; 2018; 156():63-82. PubMed ID: 29747824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia.
    Boukhris A; Schule R; Loureiro JL; Lourenço CM; Mundwiller E; Gonzalez MA; Charles P; Gauthier J; Rekik I; Acosta Lebrigio RF; Gaussen M; Speziani F; Ferbert A; Feki I; Caballero-Oteyza A; Dionne-Laporte A; Amri M; Noreau A; Forlani S; Cruz VT; Mochel F; Coutinho P; Dion P; Mhiri C; Schols L; Pouget J; Darios F; Rouleau GA; Marques W; Brice A; Durr A; Zuchner S; Stevanin G
    Am J Hum Genet; 2013 Jul; 93(1):118-23. PubMed ID: 23746551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of brain ganglioside acetylation patterns in mice with altered ganglioside biosynthesis.
    Mlinac K; Fabris D; Vukelić Z; Rožman M; Heffer M; Bognar SK
    Carbohydr Res; 2013 Dec; 382():1-8. PubMed ID: 24140892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B4GALNT1 induces angiogenesis, anchorage independence growth and motility, and promotes tumorigenesis in melanoma by induction of ganglioside GM2/GD2.
    Yoshida H; Koodie L; Jacobsen K; Hanzawa K; Miyamoto Y; Yamamoto M
    Sci Rep; 2020 Jan; 10(1):1199. PubMed ID: 31988291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of melanoma cells stably transfected with beta 1,4GalNAc transferase (GM2/GD2 synthase) cDNA: relative glycosyltransferase levels play a dominant role in determining ganglioside expression.
    Ruan S; Raj BK; Furukawa K; Lloyd KO
    Arch Biochem Biophys; 1995 Oct; 323(1):11-8. PubMed ID: 7487055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese hamster ovary cells lacking GM1 and GD1a synthesize gangliosides upon transfection with human GM2 synthase.
    Rosales Fritz VM; Daniotti JL; Maccioni HJ
    Biochim Biophys Acta; 1997 Nov; 1354(2):153-8. PubMed ID: 9396632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM2 gangliosidosis AB variant: first case of late onset and review of the literature.
    Ganne B; Dauriat B; Richard L; Lamari F; Ghorab K; Magy L; Benkirane M; Perani A; Marquet V; Calvas P; Yardin C; Bourthoumieu S
    Neurol Sci; 2022 Nov; 43(11):6517-6527. PubMed ID: 35925454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions.
    Yamashita T; Wu YP; Sandhoff R; Werth N; Mizukami H; Ellis JM; Dupree JL; Geyer R; Sandhoff K; Proia RL
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2725-30. PubMed ID: 15710896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural annotation of Beta-1,4-N-acetyl galactosaminyltransferase 1 (B4GALNT1) causing Hereditary Spastic Paraplegia 26.
    Dad R; Malik U; Javed A; Minassian BA; Hassan MJ
    Gene; 2017 Aug; 626():258-263. PubMed ID: 28536081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligosialogangliosides inhibit GM2- and GD3-synthesis in isolated Golgi vesicles from rat liver.
    Yusuf HK; Schwarzmann G; Pohlentz G; Sandhoff K
    Biol Chem Hoppe Seyler; 1987 May; 368(5):455-62. PubMed ID: 3113445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloned beta 1,4 N-acetylgalactosaminyltransferase synthesizes GA2 as well as gangliosides GM2 and GD2. GM3 synthesis has priority over GA2 synthesis for utilization of lactosylceramide substrate in vivo.
    Lutz MS; Jaskiewicz E; Darling DS; Furukawa K; Young WW
    J Biol Chem; 1994 Nov; 269(46):29227-31. PubMed ID: 7961890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic processing of gangliosides by normal and Salla human fibroblasts in culture. A study performed by administering radioactive GM3 ganglioside.
    Chigorno V; Tettamanti G; Sonnino S
    J Biol Chem; 1996 Sep; 271(36):21738-44. PubMed ID: 8702969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease.
    Seyrantepe V; Demir SA; Timur ZK; Von Gerichten J; Marsching C; Erdemli E; Oztas E; Takahashi K; Yamaguchi K; Ates N; Dönmez Demir B; Dalkara T; Erich K; Hopf C; Sandhoff R; Miyagi T
    Exp Neurol; 2018 Jan; 299(Pt A):26-41. PubMed ID: 28974375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity of glycosphingolipid GM2 and cholesterol accumulation in NPC1 patient-specific iPSC-derived neurons.
    Trilck M; Peter F; Zheng C; Frank M; Dobrenis K; Mascher H; Rolfs A; Frech MJ
    Brain Res; 2017 Feb; 1657():52-61. PubMed ID: 27923633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinsonian GM2 synthase knockout mice lacking mature gangliosides develop urinary dysfunction and neurogenic bladder.
    Gil-Tommee C; Vidal-Martinez G; Annette Reyes C; Vargas-Medrano J; Herrera GV; Martin SM; Chaparro SA; Perez RG
    Exp Neurol; 2019 Jan; 311():265-273. PubMed ID: 30393144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.